Posted in | News | Chemical Sensor

SpectraFluidics Develop Airborne Chemical Detection Tools

SpectraFluidics, a leader in the vapor trace chemical detection system,, declared that they have an investment alliance with In-Q-Tel (IQT), an autonomous strategic investment organization which recognizes the novel technology solutions for promoting U.S. Intelligence missions

The SpectraFluidics technology is a blend of high-surface Raman spectroscopy and free-surface microfluidics and is recently deriving a novel field for monitoring the molecular-specific, rapid responding ,mobile aerial particles at microscopic concentrations. The advanced technology will enhance the productivity, screening and efficiency, enabling the entire vapor traces monitoring in certain vital applications involving the instrumentation for laboratory analysis and test protocols. The major screening applications using this technology are employed in the field of agriculture, food production and explosives ensuring certification, quality and security.

According to Syd Ulvick, Vice President, Physical and Biological Technologies practice, IQT, SpectraFluidics is innovating an aerial chemical sensing instrument that can be hand held and the technology will overtake the current chemical-detection tools benefiting the private and public sectors.

Phil Strong, SpectraFluidics’ CEO commented that, they are pleased with the strategic investments from IQT, and that their aim is to provide secure vapor trace detection at a lower expenditure and with much higher output and dependability which can solve the problems associated with the airborne chemical detection industries.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.